+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Ligand binding domain interface: A tipping point for pharmacological agents binding with GluN1/2A subunit containing NMDA receptors



Ligand binding domain interface: A tipping point for pharmacological agents binding with GluN1/2A subunit containing NMDA receptors



European Journal of Pharmacology 844: 216-224



N-methyl D-aspartate (NMDA) receptors play a crucial role in normal brain function, pathogenesis of neurodegenerative and psychiatric disorders. Functional tetra-heteromeric NMDA receptor contains two obligatory GluN1 subunits and two identical or different non-GluN1 subunits that evolve from six different genes including four GluN2 (A-D) and two GluN3 (A-B) subunits. Since NMDA receptors confer varied physiological properties and spatiotemporal distributions in the brain, pharmacological agents that target NMDA receptors with specific GluN2 subunits have significant potential for therapeutic applications. In the present work, by using electrophysiology techniques, we have studied the role of ligand binding domain (LBD) interactions in determining the effect of well-characterized pharmacological agents including agonists, competitive antagonists, channel blockers and an allosteric modulator. Remarkably, point mutations at the distal end (site-II&III) of GluN1 LBD interface increased memantine potency up to sevenfold when co-expressed with wild type GluN2A receptors but exhibit no effect on Mg2+ activity. Conversely, mutations at the proximal end (site-I) of the LBD interface did not affect the memantine but altered Zn2+ and Mg2+ potency towards opposite directions. These results indicate that GluN1/2A LBD interface interactions play a key role in determining channel function. Further, subtle changes in LBD interaction can be readily translated to the downstream extracellular vestibule of channel pore to adopt a conformation that may affect memantine, Zn2+ and Mg2+ binding. Further studies on NMDA receptor LBD to transmembrane domain signal propagation mechanisms will help develop GluN2 subunit selective biomolecules that can be used for the treatment of neurological and psychiatric disorders.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 066010475

Download citation: RISBibTeXText

PMID: 30553788

DOI: 10.1016/j.ejphar.2018.12.023


Related references

Novel Mode of Antagonist Binding in NMDA Receptors Revealed by the Crystal Structure of the GluN1-GluN2A Ligand-Binding Domain Complexed to NVP-AAM077. Molecular Pharmacology 92(1): 22-29, 2017

Single-channel analysis of a point mutation of a conserved serine residue in the S2 ligand-binding domain of the NR2A NMDA receptor subunit. Journal of Physiology 574(Pt 2): 477-489, 2006

Age-Dependent, Subunit Specific Action of Hydrogen Sulfide on GluN1/2A and GluN1/2B NMDA Receptors. Frontiers in Cellular Neuroscience 11: 375, 2017

Single amino acid residue in the M4 domain of GluN1 subunit regulates the surface delivery of NMDA receptors. Journal of Neurochemistry 123(3): 385-395, 2012

Characterization of a soluble ligand binding domain of the NMDA receptor regulatory subunit NR3A. Journal of Neuroscience 26(17): 4559-4566, 2006

Positive Modulatory Interactions of NMDA Receptor GluN1/2B Ligand Binding Domains Attenuate Antagonists Activity. Frontiers in Pharmacology 8: 229, 2017

Ligand- and subunit-specific conformational changes in the ligand-binding domain and the TM2-TM3 linker of {alpha}1 {beta}2 {gamma}2 GABAA receptors. Journal of Biological Chemistry 285(51): 40373-40386, 2010

Crystal structure and pharmacological characterization of a novel N-methyl-D-aspartate (NMDA) receptor antagonist at the GluN1 glycine binding site. Journal of Biological Chemistry 288(46): 33124-33135, 2013

Conformational analysis of NMDA receptor GluN1, GluN2, and GluN3 ligand-binding domains reveals subtype-specific characteristics. Structure 21(10): 1788-1799, 2013

Rat neuronal nicotinic receptors containing alpha7 subunit Pharmacological properties of ligand binding and function. Society for Neuroscience Abstract Viewer & Itinerary Planner : Abstract No 158 3, 2003

Four residues of the extracellular N-terminal domain of the NR2A subunit control high-affinity Zn2+ binding to NMDA receptors. Neuron 25(3): 683-694, 2000

Reduced curvature of ligand-binding domain free-energy surface underlies partial agonism at NMDA receptors. Structure 23(1): 228-236, 2015

Crosslinking the ligand-binding domain dimer interface locks kainate receptors out of the main open state. Journal of Physiology 591(16): 3873-3885, 2013

Deletions in the carboxyl-terminal domain impair the ligand binding activity of a glutamate-binding protein of an NMDA receptor. FASEB Journal 7(7): A1087, 1993

Expression of the ligand-binding domain-containing region of retinoic acid receptors alpha, beta and gamma in Escherichia coli and evaluation of ligand-binding selectivity. Biological and Pharmaceutical Bulletin 16(4): 343-348, 1993